Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone
Magazine: Clinical and Translational Oncology
Date: Nov 1, 2009Neurology [SP] Neurophysiology [SP] Medical Oncology Breast Cancer Area
Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer.
We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.
CITATION Clin Transl Oncol. 2009 Nov;11(11):765-7
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.